Retatrutide is started at a lower dose so the body can adjust and side effects can be managed
One-third (31%) know of someone who has taken a GLP-1 for weight loss and 22% for Type 2 diabetes
Miller DT, Cortes-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, et al
Your PlexusDx provider will work with you to distinguish between expected adjustment effects and signals that you should hold steady at your current dose
Type 2 diabetes | Treatment summaries BNF/NICE
Rosen LS, Brown J, Laxa B, Boylos L, Reiswig L, Henner WD, Lum RT, Schow SR, Maack CA, Keck JG, Mascavage JC, Dombroski JA, Gomez RF, and Brown GL